InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Gamelin Erick. Director active across 1 company, notably Acrivon Therapeutics, Inc.. Cumulatively, 11 filings have been recorded. Activity tracked since 14 November 2022. The latest transaction was filed on 14 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Gamelin Erick is Chief Development Officer at Acrivon Therapeutics, Inc. He or she has 11 filings in total, and in the recent sample covering the period from 2022-11-16 to 2026-02-18, the transaction amounts are 0 EUR for buys and 0 EUR for sells, with tax withholding as the transaction nature.